RANOPTO
Analogs of RANOPTO
Find cheaper analogs and generic equivalents for RANOPTO.
Active Ingredient: RANIBIZUMAB
Product Overview
About RANOPTO
RANOPTO is a prescription medication containing the active ingredient Ranibizumab, a recombinant humanized monoclonal antibody fragment. It is designed to treat certain eye conditions, including neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion, diabetic macular edema, and choroidal neovascularization.
Key Benefits & Uses
- Treatment of neovascular (wet) age-related macular degeneration (AMD)
- Treatment of macular edema following retinal vein occlusion
- Treatment of diabetic macular edema
- Treatment of choroidal neovascularization
Active Ingredient & Action
Ranibizumab works by binding to and inhibiting the activity of vascular endothelial growth factor A (VEGF-A), a protein that promotes the growth of new blood vessels. By inhibiting VEGF-A, Ranibizumab reduces the formation of new blood vessels in the eye, which can help to slow or stop the progression of certain eye conditions.
Important Notes
RANOPTO is available by prescription only and should be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosing schedule and to report any changes in vision or eye symptoms to your doctor promptly. As with any medication, RANOPTO may cause side effects, including eye inflammation, increased intraocular pressure, and vision changes. Consult the product label or consult with your doctor for a complete list of potential side effects and contraindications.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.